Legionella pneumophila, the etiological agent of Legionnaires’ disease, replicates intracellularly in protozoan and human hosts. Successful colonization and replication of this pathogen in host cells requires the Dot/Icm type IVB secretion system, which translocates approximately 300 effector proteins into the host cell to modulate various cellular processes. In this study, we identified RavK as a Dot/Icm substrate that targets the host cytoskeleton and reduces actin filament abundance in mammalian cells upon ectopic expression. RavK harbors an H95EXXH99 motif associated with diverse metalloproteases, which is essential for the inhibition of yeast growth and for the induction of cell rounding in HEK293T cells. We demonstrate that the actin protein itself is the cellular target of RavK and that this effector cleaves actin at a site between residues Thr351 and Phe352. Importantly, RavK-mediated actin cleavage also occurs during L. pneumophila infection. Cleavage by RavK abolishes the ability of actin to form polymers. Furthermore, an F352A mutation renders actin resistant to RavK-mediated cleavage; expression of the mutant in mammalian cells suppresses the cell rounding phenotype caused by RavK, further establishing that actin is the physiological substrate of RavK. Thus, L. pneumophila exploits components of the host cytoskeleton by multiple effectors with distinct mechanisms, highlighting the importance of modulating cellular processes governed by the actin cytoskeleton in the intracellular life cycle of this pathogen. Actin is a core component of the actin cytoskeleton, which plays a crucial role in diverse cellular processes including cell migration, cytokinesis, endocytosis and vesicle trafficking. Therefore, it is not surprising that many pathogens target actin and/or proteins involved in the regulation of actin activity for their benefit. Legionella pneumophila, the etiological agent of Legionnaires’ disease, uses the Dot/Icm type IVB secretion system to transfer effectors into host cells to subvert host cellular processes for its intracellular replication. At least three Dot/Icm substrates, VipA, Ceg14 and LegK2 have been shown to modulate the host actin cytoskeleton. Here, by screening L. pneumophila Dot/Icm substrates that alter the actin cytoskeleton in mammalian cells, we have identified RavK as an additional effector that specifically disrupts actin organization. RavK harbors a canonical metalloprotease motif, which is essential for the RavK-mediated actin cytoskeleton disruption and cell- rounding phenotypes. We further demonstrate that RavK directly cleaves actin, generating a fragment with a diminished capacity to form actin filaments. Our results reveal a new mechanism for which an intravacuolar bacterium disrupts actin cytoskeleton through the cleavage of the actin molecule, rather than interfering with the endogenous actin regulation pathways or by posttranslational modification of the actin molecule, to benefit its intracellular life cycle.